Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Materials
/
Linde
LIN
Linde
Morningstar Equity Analyst Report
BU
BUMM
Invested
Community Contributor
Published
10 Jun 25
Updated
10 Jun 25
0
Set Fair Value
0
votes
Share
BUMM
's Fair Value
US$437.00
8.1% overvalued
intrinsic discount
10 Jun
US$472.42
Loading
1Y
5.7%
7D
2.8%
Author's Valuation
US$437.0
8.1% overvalued
intrinsic discount
BUMM's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
BUMM
's
Fair Value
US$437.0
8.1% overvalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
0
42b
2014
2017
2020
2023
2025
2026
2029
2030
Revenue US$41.8b
Earnings US$8.4b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.08%
Chemicals revenue growth rate
0.36%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.91%
Calculation
US$8.36b
Earnings '30
x
33.62x
PE Ratio '30
=
US$281.11b
Market Cap '30
US$281.11b
Market Cap '30
/
441.44m
No. shares '30
=
US$636.80
Share Price '30
US$636.80
Share Price '30
Discounted to 2025 @ 7.85% p.a.
=
US$436.50
Fair Value '25
